---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-090183"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2025-06-26T23:59:59+00:00"
generated_at: "2026-05-18T18:15:55.878691+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# HCW Biologics regains full Nasdaq Capital Market compliance; Panel Monitor through June 2026

## Summary
- On June 24, 2025, Nasdaq confirmed compliance with minimum stockholders' equity (Rule 5550(b)(1)).
- Had previously regained compliance with bid price, public float, and market value rules on May 13, 2025.
- All listing criteria now met; previously disclosed compliance matters closed.
- Subject to Panel Monitor for one year through June 23, 2026; failure requires hearing not plan submission.

## SEC filing metadata
- accession: 0000950170-25-090183
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2025-06-26T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000095017025090183/0000950170-25-090183-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000095017025090183/hcwb-20250626.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-090183
- JSON: https://secwatch.observer/filing/0000950170-25-090183.json
- Plain text: https://secwatch.observer/filing/0000950170-25-090183.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.